Concepedia

Publication | Open Access

Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging

DOIFull Paper Access

100

Citations

22

References

2021

Year

Stephen L. Lowe, Cynthia Evans, Sergey Shcherbinin, Yu-Shan Cheng, Brian A. Willis, Ivelina Gueorguieva, Albert Lo, Adam Fleisher, Jeffrey L. Dage, Paul Ardayfio,
The Journal of Prevention of Alzheimer s Disease

References

YearCitations

Page 1